InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

PROCEPT BioRobotics Corp

PRCT Clue Score64
United States Fiscal year ends December CIK 0001588978 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Pooja Sharma
6 Nov 2026
Chief Strat/Marketing Officer
Sell
4,710
$19.71
$92.85K
Kevin Waters
9 Sep 2026
EVP, CFO
Sell
373
$20.95
$7.82K
Barry L Templin
9 Sep 2026
EVP, Chief Technology Officer
Sell
373
$20.95
$7.82K
Alaleh Nouri
9 Sep 2026
EVP, CLO, Corp. Sec.
Sell
297
$20.95
$6.22K
Larry L Wood
7 Aug 2026
President, CEO
Buy indirect
23,900
$20.85
$498.32K
Barry L Templin
8 Jun 2026
EVP, Chief Technology Officer
Sell
358
$28.48
$10.20K
Kevin Waters
8 Jun 2026
EVP, CFO
Sell
357
$28.48
$10.17K
Alaleh Nouri
8 Jun 2026
EVP, CLO, Corp. Sec.
Sell
285
$28.48
$8.12K
Alaleh Nouri
19 Mar 2026
EVP, CLO, Corp. Sec.
Sold on a plan
2,332
$26.15
$60.97K
Alaleh Nouri
19 Mar 2026
EVP, CLO, Corp. Sec.
Sold on a plan
3,031
$25.82
$78.26K
Kevin Waters
17 Mar 2026
EVP, CFO
Sell
706
$28.15
$19.88K
Alaleh Nouri
17 Mar 2026
EVP, CLO, Corp. Sec.
Sell
304
$28.15
$8.56K
Alaleh Nouri
10 Mar 2026
EVP, CLO, Corp. Sec.
Sell
145
$26.74
$3.88K
Alaleh Nouri
10 Mar 2026
EVP, CLO, Corp. Sec.
Sell
3,098
$25.60
$79.32K
Antal Rohit Desai
9 Mar 2026
Director
Buy indirect
1,300
$25.42
$33.04K
Antal Rohit Desai
9 Mar 2026
Director
Buy indirect
53,818
$24.91
$1.34M
Antal Rohit Desai
9 Mar 2026
Director
Buy indirect
43,581
$24.08
$1.05M
Kevin Waters
6 Mar 2026
EVP, CFO
Sell
6,721
$23.70
$159.30K
Alaleh Nouri
6 Mar 2026
EVP, CLO, Corp. Sec.
Sell
6,892
$23.70
$163.35K
Antal Rohit Desai
6 Mar 2026
Director
Buy indirect
53,763
$24.10
$1.30M
Antal Rohit Desai
6 Mar 2026
Director
Buy indirect
106,554
$23.33
$2.49M
Antal Rohit Desai
5 Mar 2026
Director
Buy indirect
24,748
$26.41
$653.53K
Antal Rohit Desai
5 Mar 2026
Director
Buy indirect
142,498
$25.44
$3.63M

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 369,543
History held since 16 Sep 2021